1
Return

Folate receptor-α targeted therapies in ovarian cancer: recent advances and emerging therapeutic strategies

delete2026-06-19
delete0
PRE
AI
B
Bishal Singh
D
Dilpreet Singh
A
Abhisekh Sah *
P
Pallvi Kumari
D
Deepak Kumar
D
Deepika Sharma
DOI：10.1016/j.intimp.2026.117042delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
• FRα-targeted therapies modulate tumor–immune microenvironment. • Antibody–drug conjugates enhance immune-mediated cytotoxicity. • CAR-T and vaccines target FRα with immunotherapeutic potential. • Immune evasion and resistance limit FRα-targeted efficacy. • Combination immunotherapy improves clinical outcomes in ovarian cancer.

Journal

International Immunopharmacology cover
International Immunopharmacology
IF:
4.7
Papers:
1.6W
Citations:
4.1W

Organization

S
smt. tarawati institute of biomedical and allied sciences
Scholars:
2
Papers: 1
Citations: 0
C
central university of haryana
Scholars:
340
Papers: 166
Citations: 0
C
ct university
Scholars:
20
Papers: 12
Citations: 0
R
Raffles University
Scholars:
3
Papers: 3
Citations: 7
Cited Papers

Cited Papers

Citing Papers

Citing Papers